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Background
Malignant mesothelioma (MM) is an aggressive 
neoplasm. It most commonly affects the pleura 
(PM), but other possible locations are the  
peritoneum, the pericardium and the tunica  
vaginalis testis.1,2 The 5-year survival rate in 
Northern Jutland is 6% for men (2010-2014).3 
Incidence of PM has been significantly higher 
in the North Denmark Region (age-adjusted  
incidence (W) among males 2,7/100.000) com-
pared to the national average of (1,7/100.000) 
because of increased asbestos exposure due 
to the location of the Danish Eternit Factory A/S 
in Aalborg and two large shipyards in Aalborg 
and Frederikshavn.4
Objectives
To characterize males diagnosed with MM with 
regard to clinicopathological characteristics 
and source of asbestos exposure.
Materials and methods
Males diagnosed with MM between 2000 and 
2015 were identified from the Dept. of Pathology 
Aalborg University Hospital. Information regard-
ing disease location, method of diagnosis, TNM-
stage, WHO performance status (PS), source of 
asbestos exposure, comorbidities, treatment 
and survival was retrieved from health records. 
Men with high-risk asbestos exposure occupa-
tions were categorized as having occupational 
asbestos exposure. Data analysis was performed 
using Microsoft Excel.
Results
Two hundred thirty-seven males diagnosed with 
MM were identified. MM incidence is still increasing 
(figure 1). Pleural disease (PM) accounted for 
228/237 (96%) of cases. Occupational asbes-
tos exposure was identified in 201/237 (88%) of 
the patients (figure 2). Overall median survival 
was 12 months. In our population 65/237 (27%) 
were untreated with a median survival of 
3 months. The incidence of cardiopulmonary 
comorbidity increased with older age. Patients 
with comorbidity and PS 0-2 were less likely to 
receive chemotherapy than those with no 
comorbidity but comparable PS. (p<0.001). 
Pleural fluid cytology was diagnostic in 131/207 
(63%) of the patients where a diagnosis of MM 
was verified by subsequent biopsy.
Conclusions
The population has a high and increasing 
incidence of MM. MM is mainly related to 
occupational asbestos exposure in men. Diag-
nostic yield of pleural fluid cytology is high. The 
rationale for withholding chemotherapy in PS 
0-2 patients with cardiopulmonary comorbidity 
and how age influences the decision not to treat 
deserves further research along with the high 
incidence and diagnosis by cytology.
